Inicio > BIGG > Resultado de la búsqueda

    Resultados: 2

    Interim recommendations of the advisory committee on immunization practices for use of Moderna and Pfizer-Biontech Covid-19 vaccines in children aged 6 months–5 years: United States, june 2022

    Fleming-Dutra, Katherine E; Wallace, Megan; Moulia, Danielle L; Twentyman, Evelyn; Roper, Lauren E; Hall, Elisha; Link-Gelles, Ruth; Godfrey, Monica; Woodworth, Kate R; Anderson, Tara C; Rubis, Amy B; Shanley, Edwin; Jones, Jefferson M; Morgan, Rebecca L; Brooks, H. Oliver; Talbot, Keipp; Lee, Grace M; Bell, Beth P; Meyer, Sarah; Daley, Matthew; Oliver, Sara E.
    MMWR recomm. rep; 71 (26), 2022
    On June 17, 2022, the Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) amendments for the mRNA-1273 (Moderna) COVID-19 vaccine for use in children aged 6 months–5 years, administered as 2 doses (25 µg [0.25 mL] each), 4 weeks apart, and BNT162b2 (Pfizer-BioNTech) COVID-19 va...
    Vacuna nCoV-2019 mRNA-1273/efectos adversos, Vacuna nCoV-2019 mRNA-1273/administración & dosificación, Vacuna BNT162/efectos adversos, Vacuna BNT162/administración & dosificación, Programas de Inmunización/normas, COVID-19/prevención & control
    Texto completo

    The advisory committee on immunization practices’ recommendation for use of Moderna COVID-19 vaccine in adults aged ≥18 years and considerations for extended intervals for administration of primary series doses of mRNA COVID-19 vaccines: United States, february 2022

    Wallace, Megan; Moulia, Danielle; Blain, Amy E; Ricketts, Erin K; Minhaj, Faisal S; Link-Gelles, Ruth; Curran, Kathryn G; Hadler, Stephen C; !Asif, Amimah; Godfrey, Monica; Hall, Elisha; Fiore, Anthony; Meyer, Sarah; Su, John R; Weintraub, Eric; Oster, Matthew E; Shimabukuro, Tom T; Campos-Outcalt, Doug; Morgan, Rebecca L; Bell, Beth P; Brooks, Oliver; Talbot, H. Keipp; Lee, Grace M; Daley, Matthew F; Oliver, Sara E.
    MMWR recomm. rep; 71 (11), 2022
    The mRNA-1273 (Moderna) COVID-19 vaccine is a lipid nanoparticle-encapsulated, nucleoside-modified mRNA vaccine encoding the stabilized prefusion spike glycoprotein of SARS-CoV-2, the virus that causes COVID-19. During December 2020, the vaccine was granted Emergency Use Authorization (EUA) by the Food a...
    Vacuna nCoV-2019 mRNA-1273/inmunología, Vacuna nCoV-2019 mRNA-1273/administración & dosificación, Programas de Inmunización/normas, COVID-19/prevención & control
    Texto completo